Cargando…

A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma

More information is needed regarding the efficacy of SARS-CoV-2 mRNA vaccines in immunocompromised populations, including patients with malignant lymphoma. This study aimed to evaluate humoral responses to the second and third mRNA vaccine doses in 165 lymphoma patients by retrospective analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Tomotaka, Kusumoto, Shigeru, Kamezaki, Yoshiko, Hashimoto, Hiroya, Nishitarumizu, Nozomi, Nakanishi, Yoko, Kato, Yukiyasu, Kawai, Akimi, Matsunaga, Naohiro, Ebina, Toru, Nakamura, Tomoyuki, Marumo, Yoshiaki, Oiwa, Kana, Kinoshita, Shiori, Narita, Tomoko, Ito, Asahi, Inagaki, Atsushi, Ri, Masaki, Komatsu, Hirokazu, Aritsu, Takashi, Iida, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930006/
https://www.ncbi.nlm.nih.gov/pubmed/36790667
http://dx.doi.org/10.1007/s12185-023-03550-w